NCT07158164 2025-11-13DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentRutgers, The State University of New JerseyPhase 4 Recruiting100 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT00021047 2012-03-08Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed